Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia

N Engl J Med. 2013 Feb 28;368(9):876-8. doi: 10.1056/NEJMc1213554.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aspirin / therapeutic use
  • Benzimidazoles / therapeutic use
  • Dabigatran
  • Heparin / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Telangiectasia, Hereditary Hemorrhagic / drug therapy*
  • Warfarin / therapeutic use
  • beta-Alanine / analogs & derivatives
  • beta-Alanine / therapeutic use

Substances

  • Anticoagulants
  • Benzimidazoles
  • Platelet Aggregation Inhibitors
  • beta-Alanine
  • Warfarin
  • Heparin
  • Dabigatran
  • Aspirin